![Grünenthal Ltd, UK, Stokenchurch](/-/media/projects/corporatewebsite/uk/image/touts/568-354/office-uk.jpg?rev=333c4dc66db8475ead372ea965050401&hash=D09BA4F721DF126309C4FCA8A74B054A)
![Where we come from - The Grünenthal history](/-/media/projects/corporatewebsite/com/image/hero/1376-380/second-navigation-level/history-1376x380.jpg?rev=b53bad966dd541e4906f804444e17ecd&hash=84B942930CA5E28B96AB4B5470AE9508)
Where we come from
Although firmly rooted in Germany, today we are very much a growing global business. As an integrated research and development company, we have a strong track record of bringing pain treatments to patients.
Grünenthal Ltd., UK, a subsidiary of Grünenthal GmbH, was established in 2004.
With headquarters in TOR Buildings, Saint-Cloud Way, Maidenhead SL6 8BN, the company includes Regulatory, Medical Information, Sales and Marketing divisions as well as Market Access and Medical Science Liaison teams.
![Grünenthal Ltd, UK, Stokenchurch](/-/media/projects/corporatewebsite/uk/image/touts/568-354/office-uk.jpg?rev=333c4dc66db8475ead372ea965050401&hash=D09BA4F721DF126309C4FCA8A74B054A)
![Recivit®](/-/media/projects/corporatewebsite/uk/image/touts/568-354/recivit-tout1_secondary_568x354px.jpeg?rev=4d6a65fd1f02400da58e27595e3a0b84&hash=63C416F7006D64B628E5C5FCEED3E727)
2014 Recivit® (fentanyl) & Palexia® (tapentadol oral solution) Launch
M-ALL-UK-01-24-0004 - January 2024